Treating genital herpes reduces HIV transmission.

  Most people with sexually acquired HIV also have herpes simplex virus type 2 (HSV-2), the cause of genital herpes.

  Co-infection with both HIV and HSV-2 is associated with increased genital HIV shedding, which may increase HIV transmission. HIV is actually shed from genital ulcers caused by HSV-2. And several HSV-2 proteins can reactivate dormant HIV infection.

  Some evidence shows suppressing HSV-2 with valcyclovir (Valtrex) reduces HIV levels in the blood and in genital secretions. It was hoped that this would translate into reduced HIV progression or transmission.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote